Clinical Trial Update: Five-year Actively Controlled Clinical Trial in New Onset Juvenile Dermatomyositis [Phase 3]

View source ↗

Summary

A five-year actively controlled Phase 3 trial in new onset juvenile dermatomyositis has completed enrollment with results posted in 2021.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Juvenile Dermatomyositis

Snippet

Sponsor: Istituto Giannina Gaslini | Conditions: Juvenile Dermatomyositis | Phase 3 | Status: COMPLETED | Results posted: 2021-03-16